drugset / Trial / NCT07076030
Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function
Non-randomizedParallel-groupDouble-blindTreatment
Summary
This clinical research study is testing the study compound petrelintide that is being developed for the weight management in people with obesity or overweight with comorbidities or related diseases. The aim of this clinical research study is to investigate whether the effects of petrelintide will be different in people with normal kidney function compared to people with impaired kidney function.
Timeline
- Start
- 2025-04-15
- Primary completion
- 2025-11-25
- Completion
- 2025-11-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Petrelintide | Protein / enzyme biologic | — | Subcutaneous |